ED
RITM icon

Exane Derivatives’s Rithm Capital RITM Stock Holding History

Exane Derivatives’s Portfolio RITM Stock Details RITM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1
Closed -$18 – 728
2018
Q3 		$18 Hold
1
– – ﹤0.01% 678
2018
Q2 		$18 Hold
1
– – ﹤0.01% 671
2018
Q1 		$17 Sell
1
-205
-100% -$3.49K ﹤0.01% 612
2017
Q4 		$3.68K Sell
206
-234
-53% -$4.12K ﹤0.01% 438
2017
Q3 		$7.36K Sell
440
-192
-30% -$3.15K ﹤0.01% 418
2017
Q2 		$9.83K Buy
632
+453
+253% +$7.5K ﹤0.01% 391
2017
Q1 		$3.04K Sell
179
-1,757
-91% -$28.8K ﹤0.01% 388
2016
Q4 		$30.4K Sell
1,936
-949
-33% -$14K 0.01% 335
2016
Q3 		$39.8K Buy
2,885
+700
+32% +$9.76K 0.01% 319
2016
Q2 		$30.2K Sell
2,185
-6,865
-76% -$88.2K 0.01% 310
2016
Q1 		$105K Buy
+9,050
New +$100K 0.01% 237

Other funds holding RITM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NSLI
Nan Shan Life Insurance Taipei City, Taiwan $2.76B AUM 6.75% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Exane Derivatives's RITM Position: Q4 2018 in Review

Exane Derivatives sold out of Rithm Capital (RITM) in Q4 2018, closing a stake of 1 share — an estimated $18 sold.

Exane Derivatives first reported a position in RITM in Q1 2016 and held it in 11 quarters. The position peaked at $105K in Q1 2016. 354 funds tracked by Wall St. Rank hold RITM as of Q4 2018.

  • Exane Derivatives reported no remaining Rithm Capital position as of Q4 2018 after selling out during the quarter.
  • Exane Derivatives sold 1 Rithm Capital share in Q4 2018, an estimated $18.
  • Exane Derivatives first reported a position in Rithm Capital in Q1 2016 and held it in 11 quarters.
  • Exane Derivatives's Rithm Capital position peaked at $105K in Q1 2016.
  • 354 funds tracked by Wall St. Rank held Rithm Capital as of Q4 2018.

Based on Exane Derivatives's 13F filing for Q4 2018, filed 31 Jan 2019.